VERONA PHARMA PLC - AMERICAN DEPOSITARY SHARES
14.94
08-五月-24 15:49:41
15 分钟延时
股票
+0.15
+0.98%
今日范围
14.70 - 15.14
ISIN
N/A
来源
NASDAQ
-
Verona Pharma plc Announces Pricing of Upsized Underwritten Public Offering
10 8月 2022 20:22:20 条件 Nasdaq GlobeNewswire
-
Verona Pharma plc Announces Proposed Underwritten Public Offering
09 8月 2022 16:16:44 条件 Nasdaq GlobeNewswire
-
Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update
09 8月 2022 03:01:03 条件 Nasdaq GlobeNewswire
-
Verona Pharma Announces Ensifentrine Meets Primary Endpoint in Phase 3 ENHANCE-2 Trial for COPD
09 8月 2022 02:00:00 条件 Nasdaq GlobeNewswire
-
08 8月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
Verona Pharma to Report Second Quarter 2022 Financial Results and Provide Corporate Update
29 7月 2022 02:00:00 条件 Nasdaq GlobeNewswire
-
09 6月 2022 02:00:00 条件 Nasdaq GlobeNewswire
-
Verona Pharma to Host KOL Event on June 16, 2022
06 6月 2022 02:00:00 条件 Nasdaq GlobeNewswire
-
Verona Pharma to Present at Jefferies Healthcare Conference
25 5月 2022 02:00:00 条件 Nasdaq GlobeNewswire
-
09 5月 2022 02:00:00 条件 Nasdaq GlobeNewswire
-
Verona Pharma Announces May 2022 Investor Conference Participation
04 5月 2022 02:00:00 条件 Nasdaq GlobeNewswire
-
Verona Pharma Reports First Quarter 2022 Financial Results and Provides Corporate Update
03 5月 2022 02:00:00 条件 Nasdaq GlobeNewswire
-
Verona Pharma to Report First Quarter 2022 Financial Results and Provide Corporate Update
19 4月 2022 02:00:00 条件 Nasdaq GlobeNewswire
-
James Brady Joins Verona Pharma as Non-Executive Director
14 3月 2022 03:00:00 条件 Nasdaq GlobeNewswire
-
03 3月 2022 02:00:00 条件 Nasdaq GlobeNewswire
-
17 2月 2022 02:00:00 条件 Nasdaq GlobeNewswire
-
24 1月 2022 02:00:00 条件 Nasdaq GlobeNewswire
-
Verona Pharma Completes Enrollment in ENHANCE-1 48-week Subset
05 1月 2022 02:00:00 条件 Nasdaq GlobeNewswire
-
Verona Pharma to Present at H.C. Wainwright BioConnect Virtual Conference
04 1月 2022 02:00:00 条件 Nasdaq GlobeNewswire
-
16 12月 2021 02:00:00 条件 Nasdaq GlobeNewswire